Semi-Mechanistic Modeling of Florfenicol Time-Kill Curves and Dose Fractionation for Calf Respiratory Pathogens.

An important application of time-kill curve (TKC) assays is determination of the nature of the best PK/PD index (AUC/MIC or T% > MIC) and its target value for predicting clinical efficacy . VetCAST (the veterinary subcommittee of EUCAST) herein presents semi-mechanistic TKC modeling for florfenicol, a long acting (96 h) veterinary antimicrobial drug licensed against calf pneumonia organisms ( and ) to support justification of its PK/PD and clinical breakpoint. Individual TKC assays were performed with 6 field strains of each pathogen (initial inoculum 10 CFU/mL with sampling at times at 0, 1, 2, 4, 8, and 24 h). Semi-mechanistic modeling (Phoenix NLME) allowed precise estimation of bacteria growth system (K, natural growth rate; K, death rate; B, maximum possible culture size) and florfenicol pharmacodynamic parameters (E, efficacy additive to K; EC, potency; Gamma, sensitivity). PK/PD simulations (using the present TKC model and parameters of a florfenicol population pharmacokinetic model) predicted the time-course of bacterial counts under different exposures. Of two licensed dosage regimens, 40 mg/kg administered once was predicted to be superior to 20 mg/kg administered at 48 h intervals. Furthermore, we performed dose fractionation with doses 0 - 80 mg/kg administered in 1, 2 or 4 administrations over 96 h and for MICs of 0.5, 1, 2, 4 mg/L with 2 inoculum sizes 10 and 10 CFU/mL. Regression analysis (I model) demonstrated that i) AUC/MIC outperformed T% > MIC as PK/PD index and ii) maximum efficacy (IC) was obtained when the average free plasma concentration over 96 h was equal to 1.2 to 1.4 times the MIC of and , respectively.